TERUMO CORPORATION Terumo Corporation Share Price
Equities
4543
JP3546800008
Medical Equipment, Supplies & Distribution
|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,738 JPY | +2.76% |
|
+6.14% | +18.48% |
| 04-12 | Penumbra, Inc. : The underdog in healthcare |  |
| 03-18 | Frontier Field Co., Ltd. announced that it has received funding from Terumo Corporation | CI |
| Sales 2024 | 922B 5.89B 468B | Sales 2025 * | 969B 6.2B 492B | Capitalization | 3,956B 25.29B 2,008B |
|---|---|---|---|---|---|
| Net income 2024 | 106B 680M 53.98B | Net income 2025 * | 122B 782M 62.12B | EV / Sales 2024 | 4.4 x |
| Net Debt 2024 * | 23.33B 149M 11.84B | Net cash position 2025 * | 49.56B 317M 25.15B | EV / Sales 2025 * | 4.03 x |
| P/E ratio 2024 |
38.2
x | P/E ratio 2025 * |
32.5
x | Employees | 30,207 |
| Yield 2024 |
0.81% | Yield 2025 * |
0.92% | Free-Float | 95.4% |
More Fundamentals
* Assessed data
More news
Latest transcript on Terumo Corporation
More recommendations
More press releases
More news
| 1 day | +2.76% | ||
| 1 week | +6.14% | ||
| Current month | +1.65% | ||
| 1 month | +5.82% | ||
| 3 months | +0.81% | ||
| 6 months | +15.75% | ||
| Current year | +18.48% |
1 week
2 585.00
2 801.00
1 month
2 513.002 801.00
Current year
2 267.003 014.50
1 year
1 856.003 014.50
3 years
1 708.003 014.50
5 years
1 440.003 014.50
10 years
490.253 014.50
| Managers | Title | Age | Since |
|---|---|---|---|
Toshiaki Takagi
CHM | Chairman | 66 | 31/03/81 |
Naoki Muto
DFI | Director of Finance/CFO | - | - |
Kazuhisa Senshu
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Shouji Hatano
CMP | Compliance Officer | 64 | 31/03/83 |
Hidenori Nishi
BRD | Director/Board Member | 73 | 24/06/20 |
Shinjiro Sato
BRD | Director/Board Member | 63 | 31/05/04 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 2.24% | 32 M€ | +14.63% | ||
| 1.94% | 28,258 M€ | +15.99% | - | |
| 1.90% | 15,324 M€ | +15.10% | - | |
| 1.82% | 64,792 M€ | +15.95% |
| Date | Price | Change | Volume |
|---|---|---|---|
| 15/05/24 | 2,738 | +2.76% | 1 921 700 |
| 14/05/24 | 2,664 | +0.04% | 3,748,100 |
| 13/05/24 | 2,664 | +1.39% | 2,329,500 |
| 10/05/24 | 2,627 | +0.90% | 3,068,600 |
| 09/05/24 | 2,604 | +0.93% | 1,759,100 |
Delayed Quote Japan Exchange, May 15, 2024 at 03:30 am
More quotes
Terumo Corporation specializes in the design, manufacturing and marketing of medical products and equipments. Net sales break down by family of products as follows:
- cardiac surgery devices (53.5%);
- medical products for hospitals (28.6%): medical devices, nutritional additives, oxygen, medical measuring devices (thermometers, tensiometers, glucometers, etc.), etc.;
- sanguine transfusion equipments (17.9%).
Net sales break down geographically as follows: Japan (32.9%), America (29.5%), Europe (19.6%), China (7.4%) and other (10.6%).
Calendar
06/08/2024
- Q1 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
A-
Sell
Buy
Mean consensus
BUY
Number of Analysts
13
Last Close Price
2,664
JPY
Average target price
3,255
JPY
Spread / Average Target
+22.16%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +18.48% | 25.32B | |
| -5.51% | 182B | |
| +2.33% | 111B | |
| -3.62% | 68.48B | |
| +1.52% | 49.69B | |
| +8.06% | 44.46B | |
| +6.38% | 40.67B | |
| +23.35% | 31.22B | |
| +0.67% | 26.09B | |
| -1.42% | 24.6B |
- Stock Market
- Equities
- 4543 Stock
